Found 13 results
Name | Type of Offering | Accepted Date |
---|---|---|
Elicio Therapeutics, Inc.
|
D/A | 2021-11-12 15:54:12 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001555192-21-000002
Exclusions or Exemptions
506b
Accepted Date
2021-11-12 15:54:12
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Vedantra Pharmaceuticals, Inc.
|
D | 2016-05-24 11:16:57 |
Amount To Be Raised
$1,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001140361-16-066781
Exclusions or Exemptions
506b
Accepted Date
2016-05-24 11:16:57
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Elicio Therapeutics, Inc.
|
D | 2021-10-19 14:16:57 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001555192-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-10-19 14:16:57
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Elicio Therapeutics, Inc.
|
D | 2020-03-13 12:49:13 |
Amount To Be Raised
$8,411,801
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001567619-20-006266
Exclusions or Exemptions
506b
Accepted Date
2020-03-13 12:49:13
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Elicio Therapeutics, Inc.
|
D/A | 2022-11-02 14:56:01 |
Amount To Be Raised
$50,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001555192-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-11-02 14:56:01
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vedantra Pharmaceuticals, Inc.
|
D | 2018-09-14 17:23:53 |
Amount To Be Raised
$36,235,347
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001567619-18-002672
Exclusions or Exemptions
506b
Accepted Date
2018-09-14 17:23:53
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vedantra Pharmaceuticals, Inc.
|
D | 2012-07-31 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001140361-12-034377
Exclusions or Exemptions
N/A
Accepted Date
2012-07-31
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Vedantra Pharmaceuticals, Inc.
|
D | 2018-06-05 11:04:01 |
Amount To Be Raised
$3,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001140361-18-027299
Exclusions or Exemptions
506b
Accepted Date
2018-06-05 11:04:01
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Vedantra Pharmaceuticals, Inc.
|
D | 2018-08-03 11:25:37 |
Amount To Be Raised
$14,492,501
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001140361-18-035317
Exclusions or Exemptions
506b
Accepted Date
2018-08-03 11:25:37
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Elicio Therapeutics, Inc.
|
D | 2020-07-15 11:37:58 |
Amount To Be Raised
$30,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001567619-20-013296
Exclusions or Exemptions
506b
Accepted Date
2020-07-15 11:37:58
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Elicio Therapeutics, Inc.
|
D | 2019-10-15 15:08:52 |
Amount To Be Raised
$7,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001567619-19-019555
Exclusions or Exemptions
506b
Accepted Date
2019-10-15 15:08:52
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Elicio Therapeutics, Inc.
|
D/A | 2021-11-18 16:17:12 |
Amount To Be Raised
$15,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001555192-21-000003
Exclusions or Exemptions
506b
Accepted Date
2021-11-18 16:17:12
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Elicio Therapeutics, Inc.
|
D | 2022-05-27 15:41:36 |
Amount To Be Raised
$50,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001555192
Filed Document
0001555192-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-05-27 15:41:36
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|